Trained in the use of multiple focal therapies for prostate cancer, Dr. Jamil Syed recommends HIFU for certain patients with intermediate-risk prostate cancer, especially individuals with small, well-defined tumors localized to the lateral and posterior regions of the gland.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement
Advertisement